News
Four new articles from the NIH Technology Transfer Community have been published in the most recent edition of les Nouvelles, the Licensing Executive Society’s journal. NIH is not just a funder of science but is a critical catalyst that helps transform bold ideas into treatments that reach patients
In the United States, one in four cancer deaths occur from lung cancer, however, there is a lack of lung cancer screenings and analysis available quickly and at a low cost. Scientists from the National Cancer Institute’s (NCI) Laboratory of Human Carcinogenesis have proven a unique, non-invasive
The National Cancer Institute’s (NCI) Drug Synthesis and Chemistry Branch created a potential therapeutic for various types of cancers including colon cancer and leukemia by synthesizing a fluorinated cytidine. They showed that incorporating a fluorine atom into the chemical structure of cytidine
Register for your spot at the National Cancer Institute (NCI) and Frederick National Lab’s (FNL) 2021 Technology Showcase. This event provides potential partners the opportunity to attend presentations on federal technologies ready for commercialization and/or collaboration, watch panel sessions